Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal cellular structures encompass the unique physical and biochemical components of fungal cells, such as the cell wall and cell membrane, which are essential for maintaining structural integrity and osmotic stability [1]. The fungal cell wall is primarily composed of chitin, glucans, and mannoproteins, while the cell membrane contains ergosterol, a sterol absent in mammalian cells [2]. These structures serve as the primary targets for most antifungal classes; for example, echinocandins inhibit (1,3)-beta-D-glucan synthase in the cell wall, and azoles inhibit the synthesis of ergosterol [3]. Because these targets are specific to fungi, they allow for selective toxicity, though the broad nature of this category includes various distinct molecular targets [1][4]. Disruption of these structures leads to cell lysis or growth inhibition, making them critical for treating systemic and superficial fungal infections [2][5]. Beyond structural roles, these components are involved in signal transduction, nutrient uptake, and evasion of the host immune system [2]. Therapeutic challenges include the development of resistance and the potential for cross-reactivity or toxicity in the host, particularly with drugs targeting the cell membrane [1][4].
Antifungal agents target fungal cellular structures through various mechanisms: polyenes bind to ergosterol to create pores in the cell membrane; azoles and allylamines inhibit enzymes in the ergosterol biosynthetic pathway; echinocandins inhibit (1,3)-beta-D-glucan synthase to disrupt cell wall synthesis; and antimetabolites like flucytosine interfere with nucleic acid synthesis.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cellular structures.